These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33385827)

  • 21. The rescue effect of plasma exchange for neuromyelitis optica.
    Wang KC; Wang SJ; Lee CL; Chen SY; Tsai CP
    J Clin Neurosci; 2011 Jan; 18(1):43-6. PubMed ID: 20888238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of therapeutic apheresis in patients with refractory neuromyelitis optica spectrum disorders: a single-center retrospective study.
    Zhang L; Zhuang Y; Liu X; Xu Q; Zhou L; Zou L; Jiang Y; Tian J; Yao H; Chi H; Qiu X; Yang T; Wang D; Yu Y
    Ann Palliat Med; 2021 Mar; 10(3):3105-3114. PubMed ID: 33752428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research progress on pathogenesis and clinical treatment of neuromyelitis optica spectrum disorders (NMOSDs).
    Shen X
    Clin Neurol Neurosurg; 2023 Aug; 231():107850. PubMed ID: 37390569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city.
    Ashtari F; Mehdipour R; Shaygannejad V; Mansourian M
    Mult Scler Relat Disord; 2019 Sep; 34():77-82. PubMed ID: 31233958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability.
    Cacciaguerra L; Valsasina P; Mesaros S; Martinelli V; Drulovic J; Filippi M; Rocca MA
    Radiology; 2020 Oct; 297(1):154-163. PubMed ID: 32720869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
    Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
    Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders.
    Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
    Mult Scler Relat Disord; 2018 Feb; 20():115-121. PubMed ID: 29414283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials.
    Xue T; Yang Y; Lu Q; Gao B; Chen Z; Wang Z
    Mult Scler Relat Disord; 2020 Aug; 43():102166. PubMed ID: 32442886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
    Bonnan M; Valentino R; Olindo S; Mehdaoui H; Smadja D; Cabre P
    Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
    Wang X; Yi H; Liu J; Li M; Mao ZF; Xu L; Peng FH
    J Neurol Sci; 2016 Jul; 366():3-7. PubMed ID: 27288767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
    Li R; Wang J; Li C; Liu X; Chu M; Chang Y; Wang Y; Wang X; Yu B; Ling L; Yang H; Yang H; Hu X; Qiu W
    J Neuroimmunol; 2021 Jul; 356():577604. PubMed ID: 33992860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia.
    Drulovic J; Martinovic V; Basuroski ID; Mesaros S; Mader S; Weinshenker B; Pekmezovic T
    Mult Scler Relat Disord; 2019 Nov; 36():101413. PubMed ID: 31586803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.
    Watanabe S; Nakashima I; Misu T; Miyazawa I; Shiga Y; Fujihara K; Itoyama Y
    Mult Scler; 2007 Jan; 13(1):128-32. PubMed ID: 17294622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.
    Espiritu AI; Pasco PMD
    Mult Scler Relat Disord; 2019 Aug; 33():22-32. PubMed ID: 31136907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia.
    Algahtani H; Shirah B; Ibrahim B; Malik YA; Makkawi S
    Mult Scler Relat Disord; 2021 Jan; 47():102668. PubMed ID: 33307475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective study of the adverse events of the treatment for an acute attack of neuromyelitis optica spectrum disorder.
    Veerachit-O-Larn T; Siritho S; Prayoonwiwat N
    Ther Apher Dial; 2020 Aug; 24(4):453-460. PubMed ID: 31709734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
    Lim YM; Pyun SY; Kang BH; Kim J; Kim KK
    Mult Scler; 2013 Aug; 19(9):1216-8. PubMed ID: 23263897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.